Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas
University of Chicago
University of Chicago
St. Jude Children's Research Hospital
Fondazione Italiana Linfomi - ETS
University of Washington
Abramson Cancer Center at Penn Medicine
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Thomas Jefferson University
AIDS Malignancy Consortium
OHSU Knight Cancer Institute
City of Hope Medical Center
Academic and Community Cancer Research United
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Nebraska
National Cancer Institute (NCI)
University of Nebraska
Incyte Corporation
St. Petersburg State Pavlov Medical University
Chongqing University Cancer Hospital
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Northwestern University
The Lymphoma Academic Research Organisation
City of Hope Medical Center
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
University of Washington
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Western Regional Medical Center
University of Washington
Washington University School of Medicine
Sanofi
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
La Jolla Pharmaceutical Company
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Northwestern University
Northwestern University
Fred Hutchinson Cancer Center